| 
Gaea, The Mother Earth arose from Chaos to create some of the planets
and I founded Gaea Pharma in 1994 with more modest goals.
My goal for Gaea is to share my experience to help biotechnology
and mid-sized pharma companies take innovative hospital products
through to market.
Money is increasingly limited in the industry and as a small agency
we are able to work to modest budgets and still deliver a quality
result.
- We conduct portfolio analyses to prioritise compounds for development.
- We conduct market analysis with opinion leaders to define the
most appropriate target population, their unmet medical needs,
the market size and the competition.
- We encourage clients to have Expert Panel Meetings with clinicians
who are active in clinical research in the field to gain their
input to develop or question study hypotheses so that studies
are realistic, feasible and meet clinical needs in both phase
II and III.
- We encourage clients to consider ways of conducting phase II
studies other than using high cost, slow, global CROs. Its more
demanding in planning to use other resources but with limited
available money its timely for companies to address how they implement
clinical plans.
- Gaea has working relationships with consultancies in Regulatory
Affairs in Europe for clinical trial approval, CPMP Scientific
Advice, input to specialised areas such as gene therapy, and the
development of Marketing Authorisation Applications.
My industry background is
- International marketing at Hoffmann-La Roche
- Leadership of a multi-disciplinary drug development team at
Hoffmann-La Roche
- European general management of a biotechnology company, Synergen
- European general management of a global CRO, ClinTrials.
Please call or email me
to discuss your needs.
Gaea Pharma use elephants as the company symbol and the company
supports the David Sheldrick Wild Life Trust in Kenya. Please visit
the site of The
David Sheldrick Wildlife Trust if you are interested in learning
more about this Trust's valuable work.
©Copyright Gaea Pharma Ltd
2002 |